Equine type estrogens produced by a pregnant woman carrying a Smith- Lemli-Opitz syndrome fetus

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 1157-1159

  Shackleton, Cedric H L ^a   Roitman, Esther ^a   Kratz, Lisa E ^b   Kelley, Richard I ^b  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEHYDROCHOLESTEROL; ESTRADIOL; ESTROGEN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME DEFICIENCY; ESTRIOL BLOOD LEVEL; ESTROGEN BINDING; ESTROGEN RELEASE; ESTROGEN SYNTHESIS; FEMALE; GAS CHROMATOGRAPHY; HORMONAL REGULATION; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME; STEROID ANALYSIS;

EID: 0033064938     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.3.5660     Document Type: Article

References (17)

1. Bhavnani BR. 1988 The saga of the ring B unsaturated equine estrogens. Endocr Rev 9:396-416.
2. Salhanick HA, Berliner DL. 1957 Isolation of steroids from a feminizing adrenal carcinoma. J Biol Chem 227:583.
3. Raeside JI, Liptrap RM, Milne P. 1973 Relationship of fetal gonads to urinary estrogen excretion by the pregnant mare. Am J Vet Res 34:843.
4. Raeside JI, Renaud RL. 1985 Identification of 3 beta-hydroxy-5,7-androstadien-17-one as a secretory product of the fetal horse gonad in vivo and in vitro. Endocrinol 107:415-419.
5. Tait AD, Santikarn S, Allen WR. 1983 Identification of 3 beta-hydroxy-5,7-pregnadien-20-one and 3 beta-hydroxy-5,7-androstadien-17-one as endogenous steroids in the fetal horse gonad. J Endocrinol 99:87-92.
6. Tait AD, Hodge LC, Allen WR. 1985 The biosynthesis of 3 beta-hydroxy-5,7-androstadien-17-one by the horse fetal gonad. FEBS Lett 182:107-110.
7. Starka L, Breuer H, Cedard L. 1966 Biosynthesis of equine related ring B unsaturated oestrogens in perfused human placenta. J Endocrinol 34:447-456.
8. Starka L, Breuer H. 1966 Biogenese von Ring-B-ungesatenen ostrogenen und von Nicht-phenoloschen ring-B-aromatischen steroiden beim, Pferd. Hoppe-Seylers Z Physiol Chem 344:124-139.
9. 7 estrogens by human placenta in vitro. Endocrinology 83:984.
10. Irons M, Elias ER, Salen G, Tint GS, Batta AK. 1993 Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 341:1414.
11. Kelley RI. 1996 Smith-Lemli-Opitz syndrome. In: Moser HW, Handbook of Clinical Neurology. Elsevier Science B.V., 581-597.
12. Shackleton CHL. 1993 Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Molec Biol 45:127-140.
13. Glass IA, Lamm RC, Chang T, Roitman E, Shapiro LJ, Shackleton CHL. 1998 Steroid sulphatase deficiency is the major cause of extremely low oestriol production at mid-pregnancy: a urinary steroid assay for the discrimination of steroid sulphatase deficiency from other causes. Prenat Diag 18:789-800.
14. Shackleton CHL, Roitman E, Kelley R. 1998 Neonatal urinary steroids in Smith-Lemli-Opitz syndrome associated with 7-dehydrocholesterol reductase deficiency. Steroids (submitted).
15. Kratz LE, Kelley RI. 1999 Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet 82:(in press).
16. Sharp P, Haan E, Fletcher JM, Khong TY, Carey WF. 1997 First-trimester diagnosis of Smith-Lemli-Opitz syndrome. Prenat Diag 17:355-361.
17. Irons MB, Tint GS. 1998 Prenatal diagnosis of Smith-Lemli-Opitz syndrome. Prenat Diag 18:369-372.